Saxagliptin Amide Impurity

Saxagliptin Amide Impurity is a structurally related degradation byproduct arising from the amidation of a key synthetic intermediate in the parent drug's manufacturing process. It retains the core pyrrolidine scaffold of saxagliptin but features an acylated amide moiety at the 5-position of the pyrazine ring, substituting the native sulfonamide functionality. This impurity exhibits a fully saturated heterocyclic core with a substituted amide group, conferring distinct chromatographic and spectroscopic properties. Its formation is mechanistically linked to nucleophilic attack by ammonia during API synthesis, leading to competitive amidation over sulfonamidation. This compound serves as a critical HPLC reference standard for quantifying process-related amide impurities in saxagliptin drug substance.